Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-09

Clinical Trial Results: Combining Varenicline and Guanfacine for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the combination of varenicline and guanfacine for smoking cessation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)
  • Varenicline (varenicline)

Snippet

Sponsor: Yale University | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2026-06-09